tiprankstipranks
Trending News
More News >
Great-West Lifeco (GWLIF)
OTHER OTC:GWLIF
US Market

Great-West Lifeco (GWLIF) Earnings Dates, Call Summary & Reports

Compare
1 Followers

Earnings Data

Report Date
May 06, 2026
TBA (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.96
Last Year’s EPS
0.81
Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 11, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: record base earnings and EPS growth, robust capital generation and free cash flow, significant progress at Empower (scale and margins), active capital returns (buybacks and a 10% dividend hike), and growth across key businesses (Capital Solutions, Canada, Europe adjusted). Offsetting items included quarter-to-quarter volatility in Europe (mortality and trading), lower earnings on surplus driven by falling yields and intercompany dividends, some market-driven pressures in P&C retrocession and participant outflows affecting fee mix. On balance the positives (broad-based growth, cash generation, strong shareholder returns, and scalable AI/technology initiatives) materially outweigh the transient and manageable headwinds.
Company Guidance
Management's guidance stressed continued strong capital generation and disciplined returns: they expect Empower to deliver double‑digit base earnings growth in 2026 and Lifeco to reach >19% base ROE over the medium term (2025 base ROE was 18.2% with the U.S. >20%), and to generate 70%+ of base earnings from capital‑light businesses. On capital and liquidity, base capital generation exceeded 80% of base earnings and free cash flow was ~90% of base earnings in 2025; LICAT was 128% (down from 131%) and is expected to remain above 125% in 2026, leverage was 28% (up 1 ppt), and holding‑company cash was ~$2.1bn (deployable cash >$2bn). They reaffirmed a high return‑of‑capital posture—28m shares repurchased for >$1.6bn in 2025, $250m repurchased YTD 2026, an NCIB for up to 20m shares, and a 10% quarterly dividend increase to $0.60—noting they would likely return an amount similar to 2025 absent compelling M&A. Other quantified expectations included an effective tax rate rising from <16% in 2025 (a ~$0.10/sh tax benefit included) toward ~18% by 2028, credit losses of 4–6 bps of fixed income (≈$70–100m post‑tax in 2026), and continued business momentum (Empower >$2.0tn AUA, total client assets $3.3tn with >$1.0tn higher‑margin AUM/advisory; Empower Wealth net new assets +14% with USD 3.4bn rollovers; CRS run‑rate insurance result +46% YoY in Q4 and +29% FY).
Record Base Earnings and EPS Growth
Delivered record base earnings for the year and third consecutive quarter; base earnings up 11% year-over-year and base earnings per share up 12% year-over-year, driving base ROE to 18.2% (up ~70 basis points).
Empower Scale and Performance
Empower crossed the USD 2 trillion mark in total client assets; Empower base earnings grew 17% year-over-year (constant currency) and Empower Wealth base earnings rose 43% year-over-year (constant currency); Empower base ROE exceeded 20% for the first time.
Total Client Assets and Higher-Margin Assets
Total client assets ended the year at $3.3 trillion, including over $1.0 trillion of higher-margin assets under management or advisement.
Strong Net Flows and Wealth Momentum
Empower reported net new asset organic growth of 14% in Wealth; planned flows in H2 2025 were USD 29 billion versus prior expectation of USD 25 billion (≈16% higher than prior expectation); record retail net flows of $4.2 billion at Irish Life.
Capital Solutions and CRS Growth
Capital and Risk Solutions: base earnings up 9% year-over-year (constant currency); Capital Solutions run-rate insurance result increased 46% year-over-year in Q4 and 29% for the full year, with a robust pipeline.
Strong Capital Generation and Free Cash Flow
Base capital generation exceeded 80% of base earnings for the full year and free cash flow represented approximately 90% of base earnings, supporting capital deployment and shareholder returns.
Shareholder Returns — Buybacks and Dividend Increase
Repurchased ~28 million shares for over $1.6 billion in 2025 and repurchased $250 million so far in 2026; renewed NCIB to repurchase up to 20 million shares; increased quarterly dividend by 10% to $0.60 per share.
Balance Sheet Flexibility and Liquidity
Deployable cash at the holding company of about $2.1 billion at year-end; LICAT ratio maintained at 128% with guidance to remain above 125% in normal conditions; leverage around 28% with capacity to deploy capital.
Canadian and European Organic Growth
Canada base earnings increased 10% year-over-year driven by insurance experience gains and stronger fee income; Europe full-year base earnings surpassed $1 billion for the first time, with 7% constant-currency growth after adjustments.
Operational and Technology Progress
Continued digital and AI initiatives (e.g., Empower workplace private markets, expanded health options, CaLi AI assistant in Canada, CARA in Irish Life) and ongoing operational streamlining that generated over $2 billion in capital benefits from U.K. balance sheet optimization since 2024.

Great-West Lifeco (GWLIF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GWLIF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 06, 2026
2026 (Q1)
0.96 / -
0.811
Feb 11, 2026
2025 (Q4)
0.94 / 0.99
0.87713.33% (+0.12)
Nov 05, 2025
2025 (Q3)
0.89 / 0.97
0.83316.67% (+0.14)
Aug 07, 2025
2025 (Q2)
0.86 / 0.91
0.81111.71% (+0.10)
May 07, 2025
2025 (Q1)
0.83 / 0.81
0.7971.83% (+0.01)
Feb 05, 2025
2024 (Q4)
0.83 / 0.88
0.7615.38% (+0.12)
Nov 06, 2024
2024 (Q3)
0.78 / 0.83
0.74511.76% (+0.09)
Aug 06, 2024
2024 (Q2)
0.76 / 0.81
0.72412.12% (+0.09)
May 01, 2024
2024 (Q1)
0.75 / 0.80
0.63625.29% (+0.16)
Feb 14, 2024
2023 (Q4)
0.73 / 0.76
0.6998.67% (+0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GWLIF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 11, 2026
$44.13$44.32+0.43%
Nov 05, 2025
$41.28$42.20+2.24%
Aug 07, 2025
$37.78$37.67-0.29%
May 07, 2025
$35.38$35.69+0.86%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Great-West Lifeco (GWLIF) report earnings?
Great-West Lifeco (GWLIF) is schdueled to report earning on May 06, 2026, TBA (Confirmed).
    What is Great-West Lifeco (GWLIF) earnings time?
    Great-West Lifeco (GWLIF) earnings time is at May 06, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is GWLIF EPS forecast?
          GWLIF EPS forecast for the fiscal quarter 2026 (Q1) is 0.96.